| The multifaceted aspects of interstitial lung disease in rheumatoid arthritis L Cavagna, S Monti, V Grosso, N Boffini, E Scorletti, G Crepaldi, ... BioMed research international 2013, 2013 | 134 | 2013 |
| Atherosclerosis and rheumatoid arthritis: more than a simple association L Cavagna, N Boffini, G Cagnotto, F Inverardi, V Grosso, R Caporali Mediators of inflammation 2012, 2012 | 121 | 2012 |
| Randomized controlled trials and real-world data: differences and similarities to untangle literature data S Monti, V Grosso, M Todoerti, R Caporali Rheumatology 57 (Supplement_7), vii54-vii58, 2018 | 115 | 2018 |
| Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs F De Nard, M Todoerti, V Grosso, S Monti, S Breda, S Rossi, ... World journal of hepatology 7 (3), 344, 2015 | 86 | 2015 |
| Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from … EG Favalli, L Sinigaglia, A Becciolini, V Grosso, R Gorla, C Bazzani, ... International journal of rheumatic diseases 21 (2), 422-430, 2018 | 33 | 2018 |
| Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry M Manara, R Caporali, EG Favalli, V Grosso, F Atzeni, P Sarzi Puttini, ... Clin Exp Rheumatol 35 (5), 804-809, 2017 | 33 | 2017 |
| Switching from intravenous to subcutaneous formulation of abatacept: different results in a series of 21 patients S Monti, S Breda, V Grosso, M Todoerti, C Montecucco, R Caporali The Journal of Rheumatology 42 (10), 1993-1994, 2015 | 13 | 2015 |
| THU0232 Golimumab Therapy Retention Rates in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Data from the Italian Lorhen Registry V Grosso, R Gorla, P Sarzi-Puttini, F Atzeni, R Pellerito, E Fusaro, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 280-280, 2015 | 4* | 2015 |
| FRI0314 Safety of the newer biological Dmards, TOCILIZUMAB and Abatacept, in rheumatoid arthritis (RA) patients with a history of HBV infection: A real life experience F De Nard, M Todoerti, V Grosso, S Rossi, R Caporali, C Montecucco Annals of the Rheumatic Diseases 73 (Suppl 2), 499-499, 2014 | 4 | 2014 |
| Diffuse alveolar hemorrhage as a manifestation of Behçet disease V Grosso, E Boveri, L Bogliolo, C Montecucco, R Caporali Reumatismo 65 (3), 138-141, 2013 | 3 | 2013 |
| AB0401 Anxiety and Depression in Patients with Rheumatoid Arthritis Treated with Biological Drugs: Prevalence and Relationship with Disease Activity V Grosso, F De Nard, S Breda, S Monti, M Todoerti, R Caporali, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 1027-1027, 2015 | 2 | 2015 |
| AB0788 Treating Axial-Spa to Target: Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Anti-TNFα Agents S Monti, S Breda, F De Nard, V Grosso, M Todoerti, C Montecucco, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 1162-1163, 2015 | 2 | 2015 |
| AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea F Iannone, R Caporali, V Grosso, EG Favalli, A Marchesoni, S D’Angelo, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1296-1297, 2018 | 1 | 2018 |
| SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry M Sebastiani, A Manfredi, F Iannone, E Gremese, A Bortoluzzi, EG Favalli, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 957-957, 2018 | 1 | 2018 |
| FRI0215 Comparative efficacy and retention rate of tocilizumab and tnf inhibitors used in combination with methotrexate as first-line biologic therapy in rheumatoid arthritis … EG Favalli, M Biggioggero, PS Puttini, F Atzeni, E Fusaro, V Grosso, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 564-564, 2017 | 1 | 2017 |
| AB0426 Biologic Spacing in Rheumatoid Arthritis Patients in Persistent Disease Activity Control: A Real Life Experience M Todoerti, F De Nard, S Breda, S Monti, V Grosso, F Inverardi, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 1036-1037, 2015 | 1 | 2015 |
| SAT0622 ROLE OF PREGNANCY IN FLARE AND PROGRESSION INTO DEFINED RHEUMATIC DISEASE IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: RESULTS FROM A MONOCENTRIC … F Motta, V Ramoni, R Caporali, V Grosso, B Vitolo, S Quaglini, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1406-1408, 2019 | | 2019 |
| AB0332 Golimumab Efficacy in Rheumatoid Arthritis after Conventional and Biological Treatment: Data from The Italian Lorhen Registry V Grosso, R Gorla, P Sarzi-Puttini, F Atzeni, R Pellerito, E Fusaro, ... Annals of the Rheumatic Diseases 75 (Suppl 2), 1014-1015, 2016 | | 2016 |
| AB0226 One Year Experience of A Bdmard Spacing Protocol in Real Life Rheumatoid Arthritis Patients M Todoerti, S Monti, V Grosso, F De Nard, S Breda, I Chiapparoli, ... Annals of the Rheumatic Diseases 75 (Suppl 2), 975-975, 2016 | | 2016 |
| SAT0225 Screening for Pulmonary Arterial Hypertension in Systemic Sclerosis Patients: Single Center Real-Life Performance of The Detect Algorithm F De Nard, V Codullo, V Grosso, A Gallarati, S Ghio, L Scelsi, C Raineri, ... Annals of the Rheumatic Diseases 75 (Suppl 2), 749-750, 2016 | | 2016 |
